More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
2026 Health Information and Management Systems Society (HIMSS) Global Health Conference
Abt is heading to Las Vegas to meet health agencies and tech partners reshaping how public programs use data for better decisions, faster insight, and stronger outcomes for the people they serve.
Association of Maternal and Child Health Programs (AMCHP) Annual Meeting
Our experts will bring together state and local leaders at AMCHP to explore how strategic investments can strengthen maternal and child health infrastructure, improve outcomes, and build lasting partnerships.
Needs Assessment for Medicaid Readiness
Abt helped a nonprofit prepare to deliver Enhanced Care Management services under California’s CalAIM Medicaid program.
AI Helps EPA Standardize and Sharpen Toxic Chemical Data
Abt used AI to standardize EPA off site chemical transfer data to 97% accuracy, enabling faster analysis and stronger chemical safety decisions.